Scotland Backs Bayer's Xofigo In Prostate Cancer Before England
This article was originally published in Scrip
Executive Summary
The Scottish Medicines Consortium (SMC) has published advice accepting six new medicines for use in NHS Scotland, three of which have yet to receive final vetting from NICE – the HTA body for England and Wales.